Biswa Mohan Padhy
- Infectious Diseases top 10%
- Biomaterials top 10%
- Endocrinology, Diabetes and Metabolism
- Plant Science
- Pharmacology top 10%
- Co-authors
- Vijay L. KumarSanjeev RoyRachna SehgalRashmi Ranjan MohantyYogendra Kumar GuptaSmita DasAmita SrivastavaBinod Kumar Patro
- Topics
- Phytochemistry and Bioactive Compounds (5 papers)SARS-CoV-2 and COVID-19 Research (4 papers)COVID-19 Clinical Research Studies (4 papers)
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONETrends in Pharmacological Sciences
- Partner nations
- IndiaUnited StatesUzbekistan
In The Last Decade
Biswa Mohan Padhy
32 papers receiving 521 citations
Peers
Comparison fields: 5 of 108
- Infectious Diseases 145
- Biomaterials 117
- Endocrinology, Diabetes and Metabolism 83
- Plant Science 82
- Pharmacology 79
Countries citing papers authored by Biswa Mohan Padhy
This map shows the geographic impact of Biswa Mohan Padhy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Biswa Mohan Padhy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Biswa Mohan Padhy more than expected).
Fields of papers citing papers by Biswa Mohan Padhy
This network shows the impact of papers produced by Biswa Mohan Padhy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Biswa Mohan Padhy. The network helps show where Biswa Mohan Padhy may publish in the future.
Co-authorship network of co-authors of Biswa Mohan Padhy
This figure shows the co-authorship network connecting the top 25 collaborators of Biswa Mohan Padhy. A scholar is included among the top collaborators of Biswa Mohan Padhy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Biswa Mohan Padhy. Biswa Mohan Padhy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 7 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 6 | |
| 8 | 3 | |
| 9 | 4 | |
| 10 | 5 | |
| 11 | 49 | |
| 12 | 7 | |
| 13 | 51 | |
| 14 | 3 | |
| 15 | 11 | |
| 16 | 27 | |
| 17 | 26 | |
| 18 | 32 | |
| 19 | 131 | |
| 20 | 19 |
About Biswa Mohan Padhy
Biswa Mohan Padhy is a scholar working on General Dentistry, Infectious Diseases and Biological Psychiatry, having authored 36 papers that have together received 573 indexed citations. Recurring topics across this work include Phytochemistry and Bioactive Compounds (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and COVID-19 Clinical Research Studies (4 papers). The work is most often cited by research in Pharmacology (79 citations), Biomaterials (117 citations) and Infectious Diseases (145 citations). Biswa Mohan Padhy has collaborated with scholars based in India, United States and Uzbekistan. Frequent co-authors include Vijay L. Kumar, Sanjeev Roy, Rachna Sehgal, Rashmi Ranjan Mohanty, Yogendra Kumar Gupta, Smita Das, Amita Srivastava, Binod Kumar Patro, Arvind Kumar Singh and Vijay Kumar. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Trends in Pharmacological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.